Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin-loaded detachable dissolvable microneedles for primary axillary hyperhidrosis: A pilot study on efficacy and safety
TCTR20201230002Phase 2Completed
- Sponsor
- Material and Biointerface
- Start
- Feb 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of neuronox in Primary hyperhidrosis (PH), sponsored by Material and Biointerface. Started Feb 2022; status: completed.
02
Drugs
neuronox
03
Conditions
Primary hyperhidrosis (PH)
Beyond the preview
Go deeper on TCTR20201230002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20201230002.